Updated trends in US brand-name and generic drug competition
Type
Journal articlePermalink
https://hdl.handle.net/10161/12738Published Version (Please cite this version)
10.1080/13696998.2016.1176578Publication Info
Grabowski, Henry; Long, Genia; Mortimer, Richard; & Boyo, Ani (2016). Updated trends in US brand-name and generic drug competition. Journal of Medical Economics, 19(9). pp. 836-844. 10.1080/13696998.2016.1176578. Retrieved from https://hdl.handle.net/10161/12738.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Henry G. Grabowski
Professor Emeritus of Economics
Professor Grabowski specializes in the investigation of economics in the pharmaceutical
industry, government regulation of business, and the economics of innovation. His
specific interests within these fields include intellectual property and generic competition
issues, the effects of government policy actions, and the costs and returns to pharmaceutical
R&D. He has been publishing research papers for over four decades, from his earlier
work, “The Effects of Regulatory Policy on the Incentives

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles